In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CancerVax Corp.

Division of Amgen Inc.
www.cancervax.com

Latest From CancerVax Corp.

Appointments: Merck KGaA, Myovant, Scholar Rock, C4X Discovery, Paragon Bioservices and Gamida Cell.

This week's roundup includes appointments by Merck KGaA, C4X Discovery Holdings, Paragon Bioservices and board appointments by Scholar Rock, Myovant Sciences and Gamida Cell.

Appointments BioPharmaceutical

Argos Aims To Automate Cell-Based Cancer Therapy

Eventually, someone is going to have clinical and commercial success with a personalized cancer therapy. Learning from the mistakes of Dendreon and others, Argos Therapeutics expects to be first, and automation is its key.

BioPharmaceutical

Reverse Mergers Gain Traction In Tough IPO Times

Reverse mergers like Micromet's takeover of Cancervax and Cyclacel's takeover of Xcyte Therapies illustrate both tough times for IPO contenders as well as the innovative and sometimes win-win solution a reverse merger can provide.
BioPharmaceutical

Next-Generation Cancer Immunotherapies

New approaches to cancer immunotherapy promise to change the face of cancer care in a way that will reverberate through the field for years to come. In this issue, we profile Borean Pharma, OncoMed Pharmaceuticals and Receptor Logic.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amgen Inc.
  • Senior Management
  • David F Hale, Pres. & CEO
    William R LaRue, SVP, CFO
    Martin Mattingly, EVP, Mktg. & Bus. Dev.
    Dennis E Van Epps, VP, Research
  • Contact Info
  • CancerVax Corp.
    Phone: (760) 494-4200
    2110 Rutherford Rd.
    Carlsbad, CA 92008
    USA
UsernamePublicRestriction

Register